NCT00892736 2018-06-29
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
National Cancer Institute (NCI)
Phase 1 Completed
National Cancer Institute (NCI)
AbbVie
AbbVie
AbbVie
National Cancer Institute (NCI)